Demonstrating monoclonality and maintaining cell viability in cell line development are prerequisites for efficient development of cell lines for producing therapeutic proteins. This session focusses on cytena´s single-cell dispensing technology and on setting up an automated and efficient CLD workflow for generation of high-quality clones.
CYTENA is a part of BICO. Our products aim to reduce the
organ shortage and speed up drug development by
providing accessible life science solutions that combine
biology and technology, fundamentally shifting the global healthcare industry.
Read more at BICO.com
Meet the G.PURE – Our latest innovation for automated bead-based nucleic acid purification for NGS and PCR. Learn more.
